European Medicines Agency Grants Orphan Medicinal Product Designation for SCYNEXIS’ Innovative Antifungal Ibrexafungerp for the Indication of Invasive Candidiasis

Brenda Snow
Authentic Patient Voice

David Linetsky
Point-of-Care Marketing

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Matthew Durham
Omnidynamic Marketing

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Pat Purcell
Meeting Engagement

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Amy Giles
Increasing Engagement

Joey Cohen
Medication Adherence